search
Back to results

The Impact of Intervention With High-protein Enteral Formula in SICU.

Primary Purpose

Enteral Nutrition, Critical Illness

Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Very-high protein enteral formula
Standard-high protein enteral formula
Sponsored by
Tungs' Taichung Metroharbour Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Enteral Nutrition

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 20 years of age or older.
  • Those who have stayed in the surgical intensive care unit for 24 hours or more.

Exclusion Criteria:

  • Those who cannot supply enteral nutrition within 3 days due to disease or unstable clinical conditions.
  • Those who have been fed for less than three days due to disease or unstable clinical conditions.

Sites / Locations

  • PS Lim

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

VHP(very-high protein) group

SHP(standard-high protein) group

Arm Description

In VHP(very-high protein) group, we will provide pre-digested formula of 37% protein to the experimental group for at least 3 days to up to 7 days.

SHP(standard-high protein) group is the control group, standard-high protein formula (16% of energy) would be given to the control group for at least 3 days to up to 7 days.

Outcomes

Primary Outcome Measures

Survival rate
The percentage of people in two-arm group was still alive for 28-days of time after admission to ICU.
Survival rate
The percentage of people in two-arm group was still alive for 14-days of time after admission to ICU.

Secondary Outcome Measures

ICU days
ICU days is the duration of a single episode of ICU. It is calculated by subtracting day of ICU admission from day of ICU discharge.
Hospital days
Hospital days, be equal length of stay (LOS), is the duration of a single episode of hospitalization. It is calculated by subtracting day of admission from day of discharge.
Length of ventilator
Length of ventilator is the total days of using ventilator. It is calculated by recording whether ventilator was used on the day in ICU.
Nitrogen balance
Nitrogen balance, calculated by measuring urine urea nitrogen (UUN) to assess whether the protein state is sufficient.

Full Information

First Posted
April 22, 2021
Last Updated
February 14, 2022
Sponsor
Tungs' Taichung Metroharbour Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04868318
Brief Title
The Impact of Intervention With High-protein Enteral Formula in SICU.
Official Title
The Impact of Intervention With High-protein Pre-digested Enteral Formula on Clinical Outcomes in Surgical Critically Ill Patients.
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
May 10, 2021 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Tungs' Taichung Metroharbour Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The advantage of higher protein intake has been pointed for critically ill patients. However, it is not easy to achieve no overfeeding but adequate protein intakes for critically ill patients. It is thus important to conduct a strategy to deliver an adequate protein under but no overfeeding for critically ill patients. The purpose of this study is to investigate the association of protein intakes with clinical outcomes by delivering high-protein pre-digested enteral formula to surgical critically ill patients. We are going to recruit 160 surgical critically ill patients. Patients would be randomly assigned to either control or experimental group. Very-high protein pre-digested formula (37% of energy) would be given to the experimental group, while standard-high protein formula (16% of energy) would be given to the control group for at least 3 days to up to 7 days. The patients' data were collected or calculated and included basic characteristics, mean energy and protein intakes, clinical outcomes (APACHE II score, comorbidities, days in hospital to ICU admission, length of ventilator dependence, hospital and ICU stays, and survival days). We anticipated that the results of this study could provide the benefit of high protein delivery on clinical outcomes for critically ill patients.
Detailed Description
Trial Design and Patient Population This study is an investigator-initiated, prospective, randomized controlled trial. This study is conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures were reviewed as well as approved by the Regional Hospital Ethics Committee. The written informed consent will be obtained before randomization. We will collect subjects' demographic and clinical characteristics on the first and seventh day of the intervention, including age, gender, weight, height, body mass index (BMI), Disease diagnosis, disease severity (The Acute physiology and Chronic Health Evaluation II, APACHE II), Sequential Organ Failure Assessment (SOFA) Score, disease history, ventilator parameters, body temperature, blood pressure, pulse rate and breathing frequency. The complications, length of stay in intensive care unit, total hospitalization Days, hospital mortality, 14-day survival results, 28-day survival results, days of ventilator use will be also recorded. Patients 20 years of age or older will be eligible for inclusion if they have been admitted to the surgical Intensive Care Unit (SICU) for 24 hours or more. Subjects with enteral nutrition to be clinically contraindicated by treating clinician considered will be excluded. Total of one hundred and sixty patients will be included and randomly assigned into two groups. Anthropometric and Biochemical Assessments The patients' caloric requirement will be calculated based on the guidelines for critically ill nutrition treatment published by ASPEN/SCCM in 2016, suggesting that critically ill patients should be given 25 calories per kilogram of ideal body weight. The protein requirement of patients will be calculated based on the 1.5 g/kg/day recommended by the 2017 ESPEN guidelines for the nutritional care of critically ill surgical patients. The nutritional intake and digestive tract symptoms of the patient within 7 days after entering the intensive care unit will be recorded, including nutritional intake (calories, carbohydrate, protein, fat) of enteral nutrition as well as intravenous nutrition(dosage of propofol, glucose infusion and glucosaline used...etc.),and digestive symptoms (diarrhea, bloating, Abdominal pain, constipation, nausea, vomiting... etc.). The biochemical assessments of patients will be measured on the first and seventh days of admission to the ICU, including blood routine examination, total lymphocyte counts, creatinine, blood urine nitrogen, alanine aminotransferase (ALT), aspirate aminotransferase (AST), total bilirubin, albumin, prealbumin, total protein, cholesterol, triglyceride, uric acid, electrolyte, C-reactive protein, blood sugar as well as 24-hour urine urea nitrogen (UUN). Total Lymphocyte Count and Nitrogen Balance are calculated by the following formulae. Total Lymphocyte Count (cells/mm3) = WBC×% lymphocyte Nitrogen Balance (gm/day) = (protein intake/6.25) - (UUN + 4 g obligatory loss) Intervention Formula In-kind support will be provided by Nestlé Health Science, which supplied both of the enteral nutrition formulations, Peptamen® Intense VHP and Peptamen®. Peptamen® Intense VHP (37% protein of total energy) and Peptamen® (16% protein of total energy) will be provided to two groups of subjects respectively. The trial enteral nutrition was administered for at least 3 days up to 7 days or until the patient discontinued enteral nutrition, or was discharged from the ICU, whichever occurred first.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Enteral Nutrition, Critical Illness

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
280 (Actual)

8. Arms, Groups, and Interventions

Arm Title
VHP(very-high protein) group
Arm Type
Experimental
Arm Description
In VHP(very-high protein) group, we will provide pre-digested formula of 37% protein to the experimental group for at least 3 days to up to 7 days.
Arm Title
SHP(standard-high protein) group
Arm Type
Active Comparator
Arm Description
SHP(standard-high protein) group is the control group, standard-high protein formula (16% of energy) would be given to the control group for at least 3 days to up to 7 days.
Intervention Type
Other
Intervention Name(s)
Very-high protein enteral formula
Intervention Description
Peptamen® Intense VHP (37% protein)
Intervention Type
Other
Intervention Name(s)
Standard-high protein enteral formula
Intervention Description
Peptamen® (16% protein)
Primary Outcome Measure Information:
Title
Survival rate
Description
The percentage of people in two-arm group was still alive for 28-days of time after admission to ICU.
Time Frame
28 days
Title
Survival rate
Description
The percentage of people in two-arm group was still alive for 14-days of time after admission to ICU.
Time Frame
14 days.
Secondary Outcome Measure Information:
Title
ICU days
Description
ICU days is the duration of a single episode of ICU. It is calculated by subtracting day of ICU admission from day of ICU discharge.
Time Frame
28 days
Title
Hospital days
Description
Hospital days, be equal length of stay (LOS), is the duration of a single episode of hospitalization. It is calculated by subtracting day of admission from day of discharge.
Time Frame
28 days
Title
Length of ventilator
Description
Length of ventilator is the total days of using ventilator. It is calculated by recording whether ventilator was used on the day in ICU.
Time Frame
28 days
Title
Nitrogen balance
Description
Nitrogen balance, calculated by measuring urine urea nitrogen (UUN) to assess whether the protein state is sufficient.
Time Frame
7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 20 years of age or older. Those who have stayed in the surgical intensive care unit for 24 hours or more. Exclusion Criteria: Those who cannot supply enteral nutrition within 3 days due to disease or unstable clinical conditions. Those who have been fed for less than three days due to disease or unstable clinical conditions.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pei-Rong Li
Organizational Affiliation
Tungs' Taichung MetroHarbor Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yi-Chia Huang
Organizational Affiliation
Chung Shan Medical University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Shung-Sheng Tsou
Organizational Affiliation
Tungs' Taichung MetroHarbor Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Li-Wa Liao
Organizational Affiliation
Tungs' Taichung MetroHarbor Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Feng-Chan Shi
Organizational Affiliation
Tungs' Taichung MetroHarbor Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
PS Lim
City
Taichung
ZIP/Postal Code
435
Country
Taiwan

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Impact of Intervention With High-protein Enteral Formula in SICU.

We'll reach out to this number within 24 hrs